Transforming Lung Cancer Screening with AI

AI and cloud tech revolutionize lung cancer screening

Bayer at ECR 2025: Shaping Radiology with Contrast & AI

Philips launches RADIQAL study to generate real-world evidence for new ultra-low X-ray dose technology in coronary procedures

Global multi-center trial to evaluate dose reduction, image quality, and procedural performance in routine clinical settings

Lunit to Power Germany’s Largest Private Radiology Network with AI Imaging

Five-year agreement enables large-scale deployment of AI diagnostic tools across 79 Starvision sites nationwide

Bayer Launches Centafore™ Imaging Core Lab to Support Imaging for Clinical Trials and Software as a Medical Device Development

New imaging CRO offers full-spectrum services from early research to Phase IV trials and SaMD development across multiple therapeutic areas

Positive results from Phase III study for Bayer’s investigational contrast agent gadoquatrane